Brompheniramine oral

Out of stock

Dosing & Uses

ADULT  PEDIATRIC  and GERIATRIC

Dosage Forms & Strengths

tablet

  • 11mg

oral suspension

  • 12mg/5mL

liquid

  • 1mg/mL
  • 2mg/5mL

Symptomatic relief of upper respiratory symptoms, including nasal congestion, associated with allergy or common cold

 

<12 Years Old

0.5 mg/kg/day divided q6hr PO  

Warnings

Contraindications

Newborn infants, premature infants

Nursing mothers

Severe hypertension, severe coronary artery disease, severe ischemic heart disease

Within 14 days of taking monoamine oxidase (MAO) inhibitors

Narrow-angle glaucoma

Urinary retention

Peptic ulcer

During asthma attack

Treatment of lower respiratory tract conditions including asthma

Caution

Therapy may diminish mental alertness, and may cause hyperexcitability, especially in children

At doses higher than recommended dose, nervousness, dizziness, or sleeplessness may occur

Especially in infants and small children, antihistamines in overdosage may cause hallucinations, convulsions, and death

Use with caution in patients with hypertension, ischemic heart disease, and persons >60 years old

Not for administration to children who have a chronic pulmonary disease, breathing problems such as chronic bronchitis, glaucoma, or those who are taking sedatives or tranquilizers without first consulting with a doctor

Use caution in patients with hypertension, diabetes mellitus, ischemic heart disease, hyperthyroidism, increased intraocular pressure, and prostatic hypertrophy

Do not exceed recommended dosage

Discontinue use and contact healthcare professional if nervousness, dizziness, or sleeplessness occurs

Drug interaction overview

  • Not for use in patients taking a prescription monoamine oxidase (MAO) inhibitor (certain drugs used for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping MAO inhibitor
  • MAO inhibitors prolong and intensify anticholinergic effects of antihistamines and may enhance effect of pseudoephedrine HCl
  • Sympathomimetic agents may reduce effects of anti-hypertensive drugs
  • Antihistamines have additive effects with alcohol and other CNS (central nervous system) depressants (hypnotics, sedatives, tranquilizers, anti-anxiety agents, etc)

Pregnancy & Lactation

Pregnancy

Animal reproductive studies not performed with brompheniramine; also, not known if it can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity; therapy should be given to a pregnant woman only if clearly needed

Lactation

Because of higher risk of intolerance of antihistamines in small infants generally, and in newborns and premature in particular, therapy is contraindicated in nursing mothers

Warnings

Contraindications

Newborn infants, premature infants

Nursing mothers

Severe hypertension, severe coronary artery disease, severe ischemic heart disease

Within 14 days of taking monoamine oxidase (MAO) inhibitors

Narrow-angle glaucoma

Urinary retention

Peptic ulcer

During asthma attack

Treatment of lower respiratory tract conditions including asthma

Caution

Therapy may diminish mental alertness, and may cause hyperexcitability, especially in children

At doses higher than recommended dose, nervousness, dizziness, or sleeplessness may occur

Especially in infants and small children, antihistamines in overdosage may cause hallucinations, convulsions, and death

Use with caution in patients with hypertension, ischemic heart disease, and persons >60 years old

Not for administration to children who have a chronic pulmonary disease, breathing problems such as chronic bronchitis, glaucoma, or those who are taking sedatives or tranquilizers without first consulting with a doctor

Use caution in patients with hypertension, diabetes mellitus, ischemic heart disease, hyperthyroidism, increased intraocular pressure, and prostatic hypertrophy

Do not exceed recommended dosage

Discontinue use and contact healthcare professional if nervousness, dizziness, or sleeplessness occurs

Drug interaction overview

  • Not for use in patients taking a prescription monoamine oxidase (MAO) inhibitor (certain drugs used for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping MAO inhibitor
  • MAO inhibitors prolong and intensify anticholinergic effects of antihistamines and may enhance effect of pseudoephedrine HCl
  • Sympathomimetic agents may reduce effects of anti-hypertensive drugs
  • Antihistamines have additive effects with alcohol and other CNS (central nervous system) depressants (hypnotics, sedatives, tranquilizers, anti-anxiety agents, etc)

Pregnancy & Lactation

Pregnancy

Animal reproductive studies not performed with brompheniramine; also, not known if it can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity; therapy should be given to a pregnant woman only if clearly needed

Lactation

Because of higher risk of intolerance of antihistamines in small infants generally, and in newborns and premature in particular, therapy is contraindicated in nursing mothers